Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

A Randomized Phase III Study of the Treatment of Children and Adolescents With Refractory or Relapsed Acute Myeloid Leukemia

NCT00186966 is registered in ClinicalTrials.gov with Dutch Childhood Oncology Group as lead sponsor.

NCT NCT00186966
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT00186966 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
A Randomized Phase III Study of the Treatment of Children and Adolescents With Refractory or Relapsed Acute Myeloid Leukemia
Lead sponsor
Dutch Childhood Oncology Group
Phase
Phase 3
Overall status
Completed
Start date
March 31, 2002
Completion date
September 30, 2010
Enrollment
394 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

acute myeloid leukemia